Evercore Wealth Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Evercore Wealth Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5	Closed	–	–	906
2017 Q4	$0	Hold	5	–	–	﹤0.01%	947
2017 Q3	$0	Hold	5	–	–	﹤0.01%	990
2017 Q2	$0	Hold	5	–	–	﹤0.01%	1076
2017 Q1	$0	Hold	5	–	–	﹤0.01%	1079
2016 Q4	$0	Buy	+5	New	+$18	﹤0.01%	1138
2016 Q3	–	Sell	-5	Closed	–	–	1082
2016 Q2	$0	Hold	5	–	–	﹤0.01%	1058
2016 Q1	$0	Hold	5	–	–	﹤0.01%	1047
2015 Q4	$0	Hold	5	–	–	﹤0.01%	1102
2015 Q3	$0	Hold	5	–	–	﹤0.01%	1094
2015 Q2	$0	Hold	5	–	–	﹤0.01%	1116
2015 Q1	$1K	Hold	5	–	–	﹤0.01%	988
2014 Q4	$0	Hold	5	–	–	﹤0.01%	1031
2014 Q3	$0	Hold	5	–	–	﹤0.01%	1024
2014 Q2	$0	Hold	5	–	–	﹤0.01%	1063
2014 Q1	$0	Hold	5	–	–	﹤0.01%	937
2013 Q4	$0	Hold	5	–	–	﹤0.01%	1027
2013 Q3	$0	Hold	5	–	–	﹤0.01%	1023
2013 Q2	$0	Buy	+5	New	+$187	﹤0.01%	797

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Evercore Wealth Management's PTX Position: Q1 2018 in Review

Evercore Wealth Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2018, closing a stake of 5 shares.

Evercore Wealth Management first reported a position in PTX in Q2 2013 and held it in 18 quarters. The position peaked at $1K in Q1 2015. 33 funds tracked by Wall St. Rank hold PTX as of Q1 2018.

Evercore Wealth Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2018 after selling out during the quarter.
Evercore Wealth Management sold 5 Pernix Therapeutics Holdings, Inc. shares in Q1 2018.
Evercore Wealth Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 18 quarters.
Evercore Wealth Management's Pernix Therapeutics Holdings, Inc. position peaked at $1K in Q1 2015.
33 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2018.

Based on Evercore Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.